GlobeNewswire 04-15 Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pip...
GlobeNewswire 04-12 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnolo...
GlobeNewswire 04-04 Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 04-04 Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee
GlobeNewswire 03-31 Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Confere...
GlobeNewswire 03-03 Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD
GlobeNewswire 02-28 Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 02-25 Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference
GlobeNewswire 02-05 Adverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Confe...
GlobeNewswire 2024-08-12 Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corpo...
GlobeNewswire 2024-08-02 Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Confe...
GlobeNewswire 2024-08-01 Adverum Biotechnologies Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Gran...
GlobeNewswire 2024-07-25 Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
GlobeNewswire 2024-07-24 Emerging Gene Therapies Signal Transformative Shift in Retinal Disorder Treatment, According to Sphe...
GlobeNewswire 2024-07-17 Adverum Biotechnologies Presents Positive Ixo-vec Clinical Data from the 26-Week Interim Analysis of...
GlobeNewswire 2024-07-10 Adverum Biotechnologies to Host Webcast to Review Clinical Data from the 26-Week Interim Analysis of...
GlobeNewswire 2024-06-18 Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit
GlobeNewswire 2024-06-11 Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire 2024-05-23 atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire 2024-05-09 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...
GlobeNewswire 2024-05-03 Adverum Biotechnologies to Participate in Upcoming May Investor Conferences
GlobeNewswire 2024-05-01 Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Mark...
GlobeNewswire 2024-04-25 Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientif...
GlobeNewswire 2024-04-09 Opthea Appoints John Han, PharmD, as VP Medical Affairs
GlobeNewswire 2024-03-19 US Retinal Specialists Highlight the Greatest Opportunity for Gene Therapies